Absorption |
Blood-Brain Barrier | BBB+ | 0.7902 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2- | 0.6154 |
P-glycoprotein Substrate | Substrate | 0.6126 |
P-glycoprotein Inhibitor | Inhibitor | 0.7355 |
Non-inhibitor | 0.7629 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6165 |
Distribution |
Subcellular localization | Mitochondria | 0.8478 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7085 |
CYP450 2D6 Substrate | Non-substrate | 0.7220 |
CYP450 3A4 Substrate | Substrate | 0.7015 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5068 |
CYP450 2C9 Inhibitor | Inhibitor | 0.7889 |
CYP450 2D6 Inhibitor | Inhibitor | 0.7603 |
CYP450 2C19 Inhibitor | Inhibitor | 0.7941 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.6915 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9322 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6042 |
Inhibitor | 0.8368 |
AMES Toxicity | Non AMES toxic | 0.5606 |
Carcinogens | Non-carcinogens | 0.6802 |
Fish Toxicity | High FHMT | 0.9992 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9886 |
Honey Bee Toxicity | Low HBT | 0.9320 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.5539 |
Carcinogenicity (Three-class) | Non-required | 0.5278 |